pyruvic acid has been researched along with u 0126 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lodi, A; Ronen, SM; Woods, SM | 1 |
| Horiuchi, Y; Kano, F; Murata, M; Nakatsu, D | 1 |
2 other study(ies) available for pyruvic acid and u 0126
| Article | Year |
|---|---|
Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells.
Topics: Breast Neoplasms; Butadienes; Cell Line, Tumor; Female; Humans; Lactic Acid; Male; MCF-7 Cells; Mitogen-Activated Protein Kinase Kinases; Nitriles; Prostatic Neoplasms; Pyruvic Acid | 2013 |
Pyruvate kinase M1 interacts with A-Raf and inhibits endoplasmic reticulum stress-induced apoptosis by activating MEK1/ERK pathway in mouse insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Butadienes; Carrier Proteins; Caspase 3; Caspase 9; Cell Line, Tumor; eIF-2 Kinase; Endoplasmic Reticulum Stress; Endoribonucleases; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Knockdown Techniques; Insulinoma; MAP Kinase Signaling System; Membrane Proteins; Mice; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Nitriles; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins A-raf; Pyruvic Acid; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2017 |